Page results
-
Our new report shows the difference charitable funds can make to patients, staff and research at UCLH
-
This page contains information for patients (and their family and carers) who are considering having ablation for a liver tumour.
-
Mr Patrick Grover is a neurosurgeon with a particular expertise in the management of tumours of the skull base such as vestibular schwannomas and meningiomas, as well as Cerebral Aneurysms, AVMs and cavernomas.
-
Mr Pat O'Brien has been a consultant at UCLH since 1999 and specialises in caring for women with medical problems in pregnancy and complicated births. His research interests are in the same areas.
-
This page contains information for patients (and their family and carers) who are considering having ablation for a lung tumour.
-
Mr Laurence Watkins is a consultant neurosurgeon with sub-speciality interests in hydrocephalus, neurovascular surgery, intracranial pressure, chronic headache and neuro-endoscopy
-
Information about activating your MyCare UCLH app.
-
Mr Jonathan Hyam is a consultant neurosurgeon who has an interest in headache, facial pain, movement disorders, and spinal pain.
-
Taking care of yourself before and during cancer treatment can make a big difference. It can help reduce treatment side effects and make you feel stronger, both physically and emotionally. It can also help you feel more in control of what's happening.
-
An ambitious project has helped make the University College Hospital Outpatients Department much more pleasant and easy to navigate.
File results
-
FOI/2021/0696 - Procurement of Robotic Process Automation (RPA)
-
FOI/2021/0704 - Language translation and interpreting services
-
FOI/2021/0708 - Treatment of dermatological conditions
-
FOI/2021/0713 - Incidence and treatment of Haemophilia A
-
FOI/2021/0714 - Data management systems of care testing devices
-
FOI/2021/0715 - Urothelial cancer treatment
-
FOI/2021/0716 - COVID-19 deaths
-
FOI/2021/0721 - Maternity units within your trust
-
FOI/2021/0723 - Covid 19 deaths
-
FOI/2021/0730 - Treatment with Ofatumumab